Calvert Investment Management’s PDL BioPharma, Inc. PDLI Stock Holding History

Calvert Investment Management’s Portfolio PDLI Stock Details PDLI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q3	–	Sell	-506,662	Closed	-$4.9M	–	621
2014 Q2	$4.9M	Buy	506,662 +16,337	+3%	+$146K	0.33%	86
2014 Q1	$4.08M	Buy	490,325 +29,109	+6%	+$249K	0.29%	94
2013 Q4	$3.89M	Buy	461,216 +21,788	+5%	+$184K	0.28%	99
2013 Q3	$3.5M	Buy	439,428 +59,737	+16%	+$480K	0.44%	91
2013 Q2	$2.93M	Buy	+379,691	New	+$2.96M	0.4%	101

Other funds holding PDLI

ACM

Americafirst Capital Management Roseville, California $74M AUM 13.49% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

AAM

Advisors Asset Management Monument, Colorado $6.01B AUM 24.74% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Calvert Investment Management's PDLI Position: Q3 2014 in Review

Calvert Investment Management sold out of PDL BioPharma, Inc. (PDLI) in Q3 2014, closing a stake of 506,662 shares — an estimated $4.9M sold.

Calvert Investment Management first reported a position in PDLI in Q2 2013 and held it in 5 quarters. The position peaked at $4.9M in Q2 2014. 231 funds tracked by Wall St. Rank hold PDLI as of Q3 2014.

Calvert Investment Management reported no remaining PDL BioPharma, Inc. position as of Q3 2014 after selling out during the quarter.
Calvert Investment Management sold 506,662 PDL BioPharma, Inc. shares in Q3 2014, an estimated $4.9M.
Calvert Investment Management first reported a position in PDL BioPharma, Inc. in Q2 2013 and held it in 5 quarters.
Calvert Investment Management's PDL BioPharma, Inc. position peaked at $4.9M in Q2 2014.
231 funds tracked by Wall St. Rank held PDL BioPharma, Inc. as of Q3 2014.

Based on Calvert Investment Management's 13F filing for Q3 2014, filed 4 Nov 2014.